View More Recent Stories

Apr 8, 2025 06:56AM Opus Genetics (IRD) Files for 19.38M Share Offering by Selling Stockholders
Apr 1, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Opus Genetics (IRD)
Mar 21, 2025 09:12AM Opus Genetics (IRD) Prices $20M Share Offering, Concurrent Private Placement with Proceeds of Over $20M
Mar 19, 2025 03:57PM Opus Genetics (IRD) reports inducement awards
Feb 26, 2025 08:04AM Opus Genetics (IRD) Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
Feb 18, 2025 07:30AM Opus Genetics (IRD) Announces Updates on OPGx-LCA5 Clinical Program
Dec 19, 2024 08:01AM Opus Genetics (IRD) Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330
Nov 13, 2024 06:52AM H.C. Wainwright Assumes Opus Genetics (IRD) at Buy
Nov 12, 2024 08:04AM Opus Genetics, Inc. (IRD) Misses Q3 EPS by 4c
View More Recent Stories